Pharmacotherapy of chronic obstructive pulmonary disease: Therapeutic considerations with a focus on inhaled corticosteroids
International and national guidelines on chronic obstructive pulmonary disease (COPD) emphasise bronchodilators as first-line therapy. However, in considering them the ‘foundation’ of treatment, attention has shifted from the fact that COPD is fundamentally an inflammatory disease. The mainstay ough...
Saved in:
| Main Authors: | Elvis M. Irusen, Thandeka Malange |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2020-12-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/5198 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment with oral or inhaled bronchodilator without inhaled corticosteroids in bronchial asthma: A dangerous weapon!
by: Shital Patil, et al.
Published: (2023-05-01) -
Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Fathur Nur Kholis, et al.
Published: (2023-01-01) -
Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-12-01) -
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents
by: Vito D’Agnano, et al.
Published: (2024-10-01) -
Minimising inhaled corticosteroids for COPD
by: Benji Heran, et al.
Published: (2024-12-01)